perfluoro-n-nonanoic acid has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheeseman, RS; Christos, TE; Kees, KL; McCaleb, ML; Patt, WC; Prozialeck, DH; Smith, TM; Steiner, KE | 1 |
| Fang, X; Gao, G; Wang, H; Zhang, X | 1 |
2 other study(ies) available for perfluoro-n-nonanoic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Perfluorocarbon-based antidiabetic agents.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Fluorocarbons; Hypoglycemic Agents; Insulin; Mice; Mice, Obese; Molecular Structure; Structure-Activity Relationship; Thiazoles; Thiazolidinediones | 1992 |
Perfluorononanoic acid disturbed the metabolism of lipid in the liver of streptozotocin-induced diabetic rats.
Topics: Animals; Biomarkers; Cholesterol; Diabetes Mellitus, Experimental; Disease Resistance; Dose-Response Relationship, Drug; Environmental Pollutants; Fatty Acids; Fluorocarbons; Lipid Metabolism; Liver; Male; Non-alcoholic Fatty Liver Disease; Random Allocation; Rats, Sprague-Dawley; Streptozocin; Triglycerides | 2015 |